Edition:
United States

Ocera Therapeutics Inc (OCRX.OQ)

OCRX.OQ on NASDAQ Stock Exchange Global Market

2.22USD
1:20pm EST
Change (% chg)

$-0.03 (-1.11%)
Prev Close
$2.25
Open
$2.30
Day's High
$2.30
Day's Low
$2.20
Volume
13,847
Avg. Vol
35,948
52-wk High
$3.91
52-wk Low
$1.77

OCRX.OQ

Chart for OCRX.OQ

About

Ocera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on acute and chronic orphan liver diseases. The Company is focused on the development and commercialization of its clinical candidate, OCR-002, for the treatment of hepatic encephalopathy (HE). OCR-002 is a molecule, ornithine... (more)

Overall

Beta: 2.48
Market Cap(Mil.): $52.07
Shares Outstanding(Mil.): 23.14
Dividend: --
Yield (%): --

Financials

  OCRX.OQ Industry Sector
P/E (TTM): -- 29.74 30.35
EPS (TTM): -1.36 -- --
ROI: -79.53 15.90 15.27
ROE: -104.42 17.00 16.60

BRIEF-Ocera Therapeutics posts Q3 loss of $0.32/share

* Ocera Therapeutics reports third quarter 2016 financial results and company update

Nov 02 2016

BRIEF-Ocera Therapeutics qtrly loss per share $0.33

* Says updates its previous guidance and expects net use of cash for 2016 to be between $22 million and $26 million

Aug 03 2016

Competitors

Earnings vs. Estimates